Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis

Benha University67 enrolled

Overview

The aim of this study is to examine if procalcitonin (PCT) can be used for early prediction of AKI septic patients in ICU.

67 patients with sepsis were enrolled in this study. On admission, PCT was measured together with serum creatinine, urea, and other inflammatory markers. Quick Sepsis-related Organ Failure Assessment was calculated at the emergency department. Patients were classified into those with Acute kidney injury (AKI) and non-AKI groups.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Acute Kidney Injury

Interventions

measure Serum procalcitonin levelDIAGNOSTIC_TEST

measuring procalcitonin level

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ICU patients with sepsis Exclusion Criteria: * Patient known to have End-stage kidney disease * Patients on Renal replacement therapy * patients without procalcitonin level within 24 hours from admission.

Outcomes

Primary Outcomes

development of AKI

elevated kidney functions creatinine or oliguria

Time frame: 28 Days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.